The recent decision in the Novartis Glivec case continues a long-established tradition of India contesting a Northern agenda on patent laws. This key global role, arising from the exceptional combination of a vibrant domestic pharmaceutical industry with civil society awareness of the public health implications of patents, has been accentuated by recent developments and has continued relevance for the global South.
The_Global_Relevance_of_Indias_Pharmaceutical_Patent_Laws (1).pdf